Quality of life in patients with colorectal metastasis and intrahepatic chemotherapy

Sarah L. Blair, Marcia Grant, David Z J Chu, Carey Cullinane, Grace Dean, Roderich E. Schwarz, Lawrence Wagman

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


Background: Liver metastasis from colorectal cancer remains an oncological challenge. Hepatic chemotherapy has been used; however, rigorous quality of life (QOL) measurements are lacking. The aim of this study was to describe unique QOL issues to formulate a specific tool for this population. Methods: A purposive sample was identified of patients treated with intrahepatic chemotherapy. Consenting patients completed a demographic tool and the City of Hope QOL Scale/Cancer Patient survey. An in-depth interview on QOL concerns was conducted, taped, and transcribed verbatim. The data from the interviews were coded to identify recurrent themes. Results: Sixteen patients participated. Physical well-being was maintained. Significantly lower subscale scores were noted for psychological, social, and spiritual domains compared with nonpatient norms (City of Hope volunteers; n = 169). Patients found intrahepatic chemotherapy convenient but were unable to pursue vigorous activity, and their sleep habits changed. Psychologically, patients felt reassured to receive specific therapy to their liver. Conclusions: Pilot evaluation of QOL in this population revealed changes in physical, psychological, social, and spiritual dimensions. Both disease- and treatment-specific concerns were identified, and the results provide evidence for items to include in a QOL questionnaire specific to this population.

Original languageEnglish (US)
Pages (from-to)144-149
Number of pages6
JournalAnnals of Surgical Oncology
Issue number2
StatePublished - Dec 1 2003


  • Colorectal cancer
  • Liver metastasis
  • Quality of life
  • Regional chemotherapy

ASJC Scopus subject areas

  • Surgery
  • Oncology


Dive into the research topics of 'Quality of life in patients with colorectal metastasis and intrahepatic chemotherapy'. Together they form a unique fingerprint.

Cite this